Technology > Publications
- Interleukin-1 and ischemic brain injury in the newborn: development of a small molecule inhibitor of IL-1 receptor. Quiniou C, Kooli E, Joyal JS, Sapieha P, Sennlaub F, Lahaie I, Shao Z, Hou X, Hardy P, Lubell W, Chemtob S. Semin Perinatol. 2008 Oct;32(5):325-33.
- Development of a novel noncompetitive antagonist of IL-1 receptor. Quiniou C, Sapieha P, Lahaie I, Hou X, Brault S, Beauchamp M, Leduc M, Rihakova L, Joyal JS, Nadeau S, Heveker N, Lubell W, Sennlaub F, Gobeil F Jr, Miller G, Pshezhetsky AV, Chemtob S. J Immunol. 2008 May 15;180(10):6977-87.
News & Events
May 19, 2010: Allostera Pharma Inc. Appoints Christopher Henney as Chairman of its Board Of Directors
July 8, 2009: Allostera Pharma Inc. Closes $17M (CAD) Series A Financing
Search Site
Contact
Allostera Pharma Inc.
500 Boul Cartier Ouest
Suite 135
Laval, QC H7V 5B7 Canada
TEL +1 (450) 781-0479
FAX +1 (514) 371-4440
General Information:
info@allostera.com
Business Development Inquiries:
cnicolino@allostera.com
R&D Inquiries:
sbarney@allostera.com